Development of a novel small molecule, UTL-5G, to treat oxaliplatin-induced throm

Ended Project Grant Awarded Last action

Award ID
R43CA174007
Recipient
Awarding agency
Obligated
$276,418

Award facts

Assistance listing
93.395 Cancer Treatment Research
Completion date
Place of performance
Ferndale, MI 48220, USA

Award details come from USAspending.gov.

Quick answers

Who received award R43CA174007?

R43CA174007 was awarded to 21St Century Therapeutics, Inc. by National Institutes of Health (Department of Health and Human Services) on May 1, 2013.

How much is award R43CA174007 worth?

$276,418 has been obligated on R43CA174007.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award